Wealthspring Capital’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-359,250
Closed -$3.69M – 107
2023
Q2
$3.69M Buy
359,250
+294,625
+456% +$3.01M 5.12% 5
2023
Q1
$654K Buy
64,625
+27,125
+72% +$273K 1.07% 30
2022
Q4
$371K Buy
+37,500
New +$369K 0.56% 59

Wealthspring Capital's DALS Position: Q3 2023 in Review

Wealthspring Capital sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q3 2023, closing a stake of 359,250 shares — an estimated $3.69M sold.

Wealthspring Capital first reported a position in DALS in Q4 2022 and held it in 3 quarters. The position peaked at $3.69M in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • Wealthspring Capital reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
  • Wealthspring Capital sold 359,250 DA32 Life Science Tech Acquisition Corp shares in Q3 2023, an estimated $3.69M.
  • Wealthspring Capital first reported a position in DA32 Life Science Tech Acquisition Corp in Q4 2022 and held it in 3 quarters.
  • Wealthspring Capital's DA32 Life Science Tech Acquisition Corp position peaked at $3.69M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q3 2023.

Based on Wealthspring Capital's 13F filing for Q3 2023, filed 19 Oct 2023.